These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 2106392

  • 1. Lysing of fresh human tumor by a cytotoxic factor derived from autologous large granular lymphocytes independently of other known cytokines.
    Uchida A, Fujimoto T, Mizutani Y.
    Cancer Immunol Immunother; 1990; 31(1):60-4. PubMed ID: 2106392
    [Abstract] [Full Text] [Related]

  • 2. Generation of cytotoxic factor by human large granular lymphocytes during interaction with autologous tumor cells: lysis of fresh human tumor cells.
    Uchida A, Klein E.
    J Natl Cancer Inst; 1988 Nov 02; 80(17):1398-403. PubMed ID: 3262773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
    Uchida A, Moore M.
    Cancer Immunol Immunother; 1985 Nov 02; 20(1):29-37. PubMed ID: 3877561
    [Abstract] [Full Text] [Related]

  • 7. Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects.
    Kawahara DJ, Kenney JS.
    Cytokine; 1991 Mar 02; 3(2):117-24. PubMed ID: 1888882
    [Abstract] [Full Text] [Related]

  • 8. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV.
    J Immunol; 1986 Oct 15; 137(8):2592-8. PubMed ID: 3760569
    [Abstract] [Full Text] [Related]

  • 9. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A, Klein E.
    J Natl Cancer Inst; 1986 Mar 15; 76(3):389-98. PubMed ID: 2419621
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 15; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 12. Granules of human CD3+ large granular lymphocytes contain a macrophage regulating factor(s) that induces macrophage H2O2 production and tumoricidal activity but decreases cell surface Ia antigen expression.
    Roussel E, Greenberg AH.
    Cell Immunol; 1991 Apr 15; 134(1):31-41. PubMed ID: 1826466
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor.
    Djeu JY, Blanchard DK.
    J Immunol; 1987 Oct 15; 139(8):2761-7. PubMed ID: 2443572
    [Abstract] [Full Text] [Related]

  • 16. Production of multiple cytokines by clones of human large granular lymphocytes.
    Allavena P, Scala G, Djeu JY, Procopio AD, Oppenheim JJ, Herberman RB, Ortaldo JR.
    Cancer Immunol Immunother; 1985 Oct 15; 19(2):121-6. PubMed ID: 3921231
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM, Reade JL, Ware CF, Devlin PE, Liang CM, Devlin JJ.
    J Immunol; 1986 Dec 01; 137(11):3488-93. PubMed ID: 2431035
    [Abstract] [Full Text] [Related]

  • 18. In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha.
    Brinchmann JE, Gaudernack G, Vartdal F.
    J Acquir Immune Defic Syndr (1988); 1991 Dec 01; 4(5):480-8. PubMed ID: 1673156
    [Abstract] [Full Text] [Related]

  • 19. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M.
    Clin Cancer Res; 1998 Mar 01; 4(3):713-20. PubMed ID: 9533541
    [Abstract] [Full Text] [Related]

  • 20. Large granular lymphocytes from patients with expanded LGL populations acquire cytotoxic functions and release lymphokines upon in vitro activation.
    Pistoia V, Prasthofer EF, Tilden AB, Barton JC, Ferrarini M, Grossi CE, Zuckerman K.
    Blood; 1986 Nov 01; 68(5):1095-100. PubMed ID: 3490286
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.